Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Chase Pharmaceuticals Corp.
DescriptionCombination of Exelon rivastigmine, an acetylcholinesterase (AChE) inhibitor, and an undisclosed pharmaceutical
Molecular Target
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today